Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 0615-8508

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0615-8508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cyclobenzaprine Tabs 8508 1)

Chemical structure of Cyclobenzaprine hydrochloride, showing the molecular arrangement including aromatic rings and the hydrochloride salt component.*

FDA Label Image

Image (Cyclobenzaprine Tabs 8508 2)

FDA Label Image

Principal Display Panel (Cyclobenzaprine Tabs 8508 3)

Cyclobenzaprine hydrochloride Tablets USP 5 mg film-coated oral tablets packaging label by NCS HealthCare of KY, LLC dba Vangard Labs. The label states the product strength as 5 mg and package quantity as 30 tablets. It includes lot number 8508 and features multiple barcodes, storage instructions at 20° to 25°C, and a notation “For Institutional Use Only.” Manufacturer is listed as Unichem with packaging by Vangard in Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.